|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1995-12-8
|
|
pubmed:abstractText |
We report a case of life-threatening hepatotoxicity following GM-CSF therapy after autologous bone marrow transplantation. GM-CSF hepatotoxicity should now be considered in the differential diagnosis of post-transplant liver disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0268-3369
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
195-7
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:7581124-Adult,
pubmed-meshheading:7581124-Bone Marrow Transplantation,
pubmed-meshheading:7581124-Diagnosis, Differential,
pubmed-meshheading:7581124-Graft Rejection,
pubmed-meshheading:7581124-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:7581124-Humans,
pubmed-meshheading:7581124-Liver Diseases,
pubmed-meshheading:7581124-Male,
pubmed-meshheading:7581124-Transplantation, Autologous
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Severe hepatotoxicity from granulocyte-macrophage colony-stimulating factor administered after autologous bone marrow transplantation.
|
|
pubmed:affiliation |
University of Toronto Autologous Blood and Marrow Transplant Program, Toronto Hospital, Ontario, Canada.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
